Your browser doesn't support javascript.
loading
Ectodysplasin A receptor (EDAR) promotes colorectal cancer cell proliferation via regulation of the Wnt/ß-catenin signaling pathway.
Wang, Bin; Liang, Yanfang; Chai, Xingxing; Chen, Shasha; Ye, Ziyu; Li, Ronggang; Li, Xiaoping; Kong, Gang; Li, Yanyun; Zhang, Xueying; Che, Zhengping; You, Yongke; Ye, Shicai; Li, Lili; Lin, Bihua; Huang, Juan; Huang, Mingyuan; Zhang, Xin; Qiu, Xianxiu; Zeng, Jincheng.
Afiliação
  • Wang B; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China. Electronic address: 781486075@qq.com.
  • Liang Y; Department of Pathology, Dongguan Hospital Affiliated to Jinan University, Marina Bay Central Hospital of Dongguan, Dongguan 523905, China. Electronic address: lyfine84@126.com.
  • Chai X; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China; Laboratory Animal Center, Guangdong Medical University, Zhanjiang 524023, China
  • Chen S; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China. Electronic address: 595867691@qq.com.
  • Ye Z; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China. Electronic address: yeziyu92@126.com.
  • Li R; Department of Pathology, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen 529030, China. Electronic address: lrg760904@163.com.
  • Li X; Department of Gastrointestinal Surgery, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen 529030, China. Electronic address: 13600033922@188.com.
  • Kong G; Department of Gastrointestinal Surgery, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen 529030, China. Electronic address: 13822340889@139.com.
  • Li Y; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China. Electronic address: 501331112@qq.com.
  • Zhang X; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China. Electronic address: 2805814447@qq.com.
  • Che Z; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China. Electronic address: chezhengping297@163.com.
  • You Y; Department of Nephrology, Shenzhen University General Hospital, Shenzhen, Guangdong, China. Electronic address: yongke.you@gmail.com.
  • Ye S; Department of Gastroenterology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China. Electronic address: caizi23@126.com.
  • Li L; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China; Laboratory Animal Center, Guangdong Medical University, Zhanjiang 524023, China
  • Lin B; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China; Collaborative Innovation Center for Antitumor Active Substance Research and Dev
  • Huang J; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China. Electronic address: huangjuan86@gdmu.edu.cn.
  • Huang M; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China. Electronic address: hmy@gdmu.edu.cn.
  • Zhang X; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China; Collaborative Innovation Center for Antitumor Active Substance Research and Dev
  • Qiu X; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China; The Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen 5180
  • Zeng J; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Medical University, Dongguan 523808, China; Collaborative Innovation Center for Antitumor Active Substance Research and Dev
Exp Cell Res ; 395(1): 112170, 2020 10 01.
Article em En | MEDLINE | ID: mdl-32682783
ABSTRACT
Colorectal cancer is the second leading cause of cancer mortality worldwide with poor prognosis and high recurrence. Aberrant Wnt/ß-catenin signaling promotes oncogenesis by transcriptional activation of c-Myc and its downstream signals. EDAR is characterized as an important effector of canonical Wnt signaling in developing skin appendages, but the interplay between EDAR and Wnt signaling in tumorigenesis and progression remains to be elucidated. In this study, we revealed that EDAR expression is prevalently elevated in colorectal cancer tissues compared with normal tissues. Further analysis suggests there is a strict correlation between EDAR expression and colorectal cancer progression. EDAR silencing by shRNA in colorectal cancer cells showed proliferative suppression via retarding cell cycle at G1 phase. Xenograft mice transplanted with shEDAR-transduced tumor cells significantly alleviated tumor burden in comparison with control mice. Furthermore, downregulation of EDAR was accompanied by reduction of ß-catenin, c-Myc and other G1 cell cycle regulators, while ß-catenin agonist restored the expression of these proteins and overrode the proliferative block induced by EDAR knockdown. These findings indicate that EDAR functions as a component of Wnt/ß-catenin signaling pathway, and is a potential modulator in colorectal carcinogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias do Colo / Proliferação de Células / Receptores da Ectodisplasina / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias do Colo / Proliferação de Células / Receptores da Ectodisplasina / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article